Kidney injury molecule-1 and cystatin C as early biomarkers for renal dysfunction in Iraqi type 2 diabetes mellitus patients

Kidney injury molecule-1 and cystatin C as early biomarkers for renal dysfunction in Iraqi type 2 diabetes mellitus patients

Diabetic kidney disease (DKD) is caused by a variety of processes. As a result, one biomarker is insufficient to represent the complete process. This study Evaluate the diagnostic value of serum kidney injury molecule-1(KIM-1) and cystatin C (CysC) as early biochemical markers of DKD and predictive...

Full description

Bibliographic Details
Main Authors:	Ansam Abdulameer Yahya, Dheyaa Jabbar Kadhim, Nassar Abdalaema Abdalhadi
Format:	Article
Language:	English
Published:	Bangladesh Society for Microbiology, Immunology, and Advanced Biotechnology 2023-12-01
Series:	Journal of Advanced Biotechnology and Experimental Therapeutics
Subjects:	keywords: diabetic kidney disease(dkd) kidney injury molecule-1 (kim-1) cystatin c(cysc)
Online Access:	http://www.ejmanager.com/fulltextpdf.php?mno=157351

Similar Items

Early Diagnosis in Acute Kidney Failure: Neutrophil Gelatinase Associated Lipocain (NGAL), Kidney Injury Molecule-1 (KIM-1), Interleukine-18 (IL-18), Cystatin C
by: Mehmet İlke Büget, et al.
Published: (2014-12-01)

Cystatin C, renal resistance index, and kidney injury molecule-1 are potential early predictors of diabetic kidney disease in children with type 1 diabetes
by: Ivana Trutin, et al.
Published: (2022-07-01)

Comparing Effects of Different Doses of Vancomycin on the Biomarkers of Acute Kidney Injury
by: Sepideh Elyasi, et al.
Published: (2019-12-01)

Clusterin as a New Marker of Kidney Injury in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation—A Pilot Study
by: Kinga Musiał, et al.
Published: (2020-08-01)

Serum KIM-1 and Cystatin Levels as the Predictors of Acute Kidney Injury in Asphyxiated Neonates
by: Mahryar Mehrkesh, et al.
Published: (2022-01-01)

Clinicopathological role of kidney injury molecule-1 in immunoglobulin A nephropathy
by: Yu Ho Lee, et al.
Published: (2014-09-01)

Assessment of renal function and acute rejection using Cystatin C and kidney injury Molecule-1 in renal transplant recipients
by: Sailaja Kesiraju, et al.
Published: (2018-01-01)

Association Between Serum Cystatin C and Thyroid Diseases: A Systematic Review and Meta-Analysis
by: Caihong Xin, et al.
Published: (2021-11-01)

Association between the ratio of serum creatinine to cystatin C and bone mineral density in Chinese older adults patients with type 2 diabetes mellitus
by: Ting Gao, et al.
Published: (2022-10-01)

Exploring the Utility of Urinary Creatinine Adjustment for KIM-1, NGAL, and Cystatin C for the Assessment of Kidney Function: Insights from the C-KidnEES Cohort
by: T. D. K. S. C. Gunasekara, et al.
Published: (2023-12-01)

Kidney injury molecule-1: A urinary biomarker for contrast-induced acute kidney injury
by: M Vijayasimha, et al.
Published: (2014-01-01)

Is urinary kidney injury molecule-1 a noninvasive marker for renal injury in patients with ureteral stones?
by: Lokman Irkilata, et al.
Published: (2016-06-01)

The outcome of acute kidney injury substages based on urinary cystatin C in critically ill children
by: Jiao Chen, et al.
Published: (2023-03-01)

The value of kidney injury molecule 1 in predicting acute kidney injury in adult patients: a systematic review and Bayesian meta-analysis
by: Jiwen Geng, et al.
Published: (2021-03-01)

Burn-Induced Acute Kidney Injury–Two-Lane Road: From Molecular to Clinical Aspects
by: Andrei Niculae, et al.
Published: (2022-08-01)

Markers of Kidney Tubular Function Deteriorate While Those of Kidney Tubule Health Improve in Primary Aldosteronism After Targeted Treatments
by: Vin‐Cent Wu, et al.
Published: (2023-02-01)

The Predicted Value of Kidney Injury Molecule-1 (KIM-1) in Healthy People
by: Peng S, et al.
Published: (2022-04-01)

Predictive Nephrotoxicity Profiling of a Novel Antifungal Small Molecule in Comparison to Amphotericin B and Voriconazole
by: Nadeeka S. Udawatte, et al.
Published: (2020-04-01)

Polymyxin B-Induced Kidney Injury Assessment of a Novel Formulation of Polymyxin B (VRP-034) in Rats
by: Dilip Roy, et al.
Published: (2021-03-01)

Establishment of muscle mass-based indications for the cystatin C test in renal function evaluation
by: Jisook Yim, et al.
Published: (2022-11-01)

Cystatin C — an Early Marker of Renal Damage in Children with Diabetes Mellitus Type 1
by: A.S. Senatorova, et al.
Published: (2013-03-01)

Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours
by: Ping’an Ding, et al.
Published: (2022-09-01)

The importance of KIM-1 determination in tissue and urine of patients with different kidney diseases
by: Simić-Ogrizović Sanja
Published: (2010-01-01)

FcER1: A Novel Molecule Implicated in the Progression of Human Diabetic Kidney Disease
by: Swastika Sur, et al.
Published: (2021-12-01)

Assessment of Subclinical Renal Glomerular and Tubular Dysfunction in Children with Beta Thalassemia Major
by: Asmaa A. Mahmoud, et al.
Published: (2021-02-01)

Comparison of Levels of Nephropathy Biomarkers in HIV-infected Individuals and Healthy Volunteers
by: Damla ERTÜRK, et al.
Published: (2023-01-01)

Cystatin C and uncontrolled hypertension
by: Mehmet Onur Omaygenç, et al.
Published: (2020-10-01)

Comparison of Serum Cystatin C and Creatinine Levels to Evaluate Early Renal Function after Kidney Transplantation
by: Hamid Eshraghi, et al.
Published: (2009-06-01)

Determination of serum KIM-1 in patients with chronic kidney injury
by: Abhishek Bansal, et al.
Published: (2023-08-01)

Deviations from the expected relationship between serum FGF23 and other markers in children with CKD: a cross-sectional study
by: Daisy Liu, et al.
Published: (2017-06-01)

Urinary cystatin C as a marker of tubular dysfunction
by: Mijušković Zoran, et al.
Published: (2007-01-01)

Cystatin C and preclinical lesions in the target organs of hypertensive patients
by: E V Oshchepkova, et al.
Published: (2014-09-01)

Association between Enzyme-Linked Immunosorbent Assay-Measured Kidney Injury Markers and Urinary Cadmium Levels in Chronic Kidney Disease
by: Kai-Fan Tsai, et al.
Published: (2021-12-01)

Cystatin C Predicts Renal Recovery Earlier Than Creatinine Among Patients With Acute Kidney Injury
by: Kamel A. Gharaibeh, et al.
Published: (2018-03-01)

Effect of up to 30-days of storage at different temperatures on detection of feline kidney injury molecule-1 in urine
by: Aleksandra Milaszewska, et al.
Published: (2022-11-01)

Divergence between serum creatine and cystatin C in estimating glomerular filtration rate of critically ill COVID-19 patients
by: Yanan Liu, et al.
Published: (2021-01-01)

Cystatin C in the diagnostics of acute kidney injury after heart transplantation
by: A. G. Strokov, et al.
Published: (2017-04-01)

Is Interleukin-18 an Early Diagnostic Biomarker in Contrast Induced Nephropathy?
by: Mohammed Mujahid, et al.
Published: (2019-03-01)

Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer
by: Jing Sun, et al.
Published: (2022-01-01)

Pharmacokinetic and Biomarker Quantification Studies on Vancomycin-Loaded PEGylated Liposomes and Its Potential to Reduce Vancomycin-Induced Kidney Injury: A Rat Study
by: Medha D. Joshi, et al.
Published: (2023-05-01)